News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Reuters poll sees Chinas May exports up about 15% year-on-year in dollar terms, driven by front-loaded orders and semiconductor demand.
  • Intesa Sanpaolo launched a 930.6 billion offer for Monte Paschi to create one of Europes largest listed banking groups, subject to approvals.
  • Naver agreed with Nvidia to build AI data centers in South Korea starting with a 55 MW project, sending its shares higher.
  • BoEs Alan Taylor said current interest rates are restrictive but sees no need to raise them absent a worst-case escalation.
  • Vietnam will prioritize expansionary fiscal support as monetary easing space narrows after a record May trade deficit and rising inflation.
  • Rackspace opened a regional headquarters in Riyadh to accelerate cloud and AI adoption across the Gulf Cooperation Council under Vision 2030.

Latest Articles

LXP Industrial Trust Provides Recent Business Activity Update and Increases 2026 Adjusted Company FFO Guidance

LXP Industrial Trust Provides Recent Business Activity Update and Increases 2026 Adjusted Company FFO Guidance

LXP Industrial Trust has reported robust leasing performance, completing 4.6 million square feet of leases year-to-date with significant rental rate increases. The company also acquired a prime 37-acre redevelopment site in Phoenix for $103 million, which is fully leased until 2031 and planned for future industrial development. Following these oper…

Microchip Technology Appoints Mitch Little to Its Board of Directors

Microchip Technology Appoints Mitch Little to Its Board of Directors

Microchip Technology Incorporated announced the appointment of Mitch Little, former senior executive at Microchip, to its Board of Directors effective June 1, 2026. Little brings extensive experience in sales, product management, and leadership, and meets Nasdaq's independence requirements. The company highlighted his role in shaping Microchip's cu…

Praxis Precision Medicines Provides Vormatrigine Program Update

Praxis Precision Medicines Provides Vormatrigine Program Update

Praxis Precision Medicines announced that the Phase 2/3 POWER1 study of vormatrigine in patients with focal onset seizures did not meet its primary endpoint of seizure frequency reduction, though a secondary measure of 50% response rate was met and higher dose showed more pronounced seizure reduction. Vormatrigine was generally well-tolerated with …

XAI Octagon Floating Rate & Alternative Income Trust Declares its Monthly Common Shares Distribution of $0.225 per Share

XAI Octagon Floating Rate & Alternative Income Trust Declares its Monthly Common Shares Distribution of $0.225 per Share

The XAI Octagon Floating Rate & Alternative Income Trust announced its monthly common share distribution of $0.225 per share, unchanged from the previous month. The distribution is payable on July 1, 2026, to shareholders of record as of June 15, 2026. The Trust invests primarily in floating rate credit instruments and structured credit investments…

Insider Activity and Recent Performance Metrics at CuriosityStream Inc.

Insider Activity and Recent Performance Metrics at CuriosityStream Inc.

The Chief Executive Officer of CuriosityStream Inc., Clinton Larry Stinchcomb, recently purchased a notable amount of the company's common stock. This transaction occurs amidst varying market signals for CuriosityStream (NASDAQ: CURI), including recent reported revenue figures that fell below expectations and strategic announcements regarding conte…

Lee Enterprises Director's Stock Purchases Amid Company Milestones

Lee Enterprises Director's Stock Purchases Amid Company Milestones

Director David Henry Hoffmann, a ten percent owner of Lee Enterprises (LEE), recently executed several transactions acquiring significant quantities of the company's common stock. These purchases occur against a backdrop of positive corporate developments for LEE, including strong second-quarter financial results and a new management agreement with…

UL Solutions Executive Divests Shares Following 10b5-1 Plan; Company Reports Strong Q1 Results and New AI Platform

UL Solutions Executive Divests Shares Following 10b5-1 Plan; Company Reports Strong Q1 Results and New AI Platform

Executive Vice President and Chief Commercial Officer Alberto Uggetti recently sold shares of UL Solutions Class A Common Stock under a pre-arranged trading plan. This transaction occurred against a backdrop of positive corporate news, including strong first quarter 2026 financial results, an announced quarterly dividend, and the launch of new AI p…

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis

Abivax reported positive Phase 3 ABTECT maintenance trial results for obefazimod, an oral miR-124 enhancer, showing significant clinical remission rates at week 44 in patients with moderately to severely active ulcerative colitis. Both 25 mg and 50 mg doses met primary and all key secondary endpoints with a favorable safety profile. The company pla…

Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review

Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review

Fulcrum Therapeutics announced discontinuation of its pociredir program for sickle cell disease after receiving FDA feedback that raised concerns about the risk of secondary malignancies linked to the drug's target, influenced by a related drug's market withdrawal. Despite positive clinical signals, the FDA sees no viable regulatory path forward. F…

Merlin, Inc. To Participate in Upcoming Investor Conferences

Merlin, Inc. To Participate in Upcoming Investor Conferences

Merlin, Inc., an aerospace and defense technology company focused on autonomous flight systems, has announced its management will take part in multiple investor conferences throughout June 2026. The events include the Jefferies Defense Tech Summit, ROTH Capital Partners Annual London Conference, and the Maxim Group Defense Tech Conference. The comp…

Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs

Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs

Minerva Neurosciences has established a Scientific Advisory Board (SAB) composed of leading experts in psychiatry and neuroscience to guide the clinical development of roluperidone, an investigational drug targeting negative symptoms of schizophrenia, and to advise on future pipeline programs. The SAB formation fulfills a prior PIPE financing commi…

SpaceX Carves Out 5% of IPO Shares for Select Employees and Appointees

SpaceX Carves Out 5% of IPO Shares for Select Employees and Appointees

A regulatory filing dated Monday shows SpaceX will reserve 5% of the shares in its planned initial public offering for certain employees and individuals chosen by executive officers, offering those shares at the IPO price through a directed share program and exempting them from typical post-IPO lock-up restrictions. The filing does not disclose the…